Oldfield Matthew D, Donley Penelope, Walwyn Linda, Scudamore Ian, Gregory Robert
Department of Diabetes, Leicester General Hospital, Leicester, UK.
Postgrad Med J. 2007 Jun;83(980):426-30. doi: 10.1136/pgmj.2006.056267.
To assess the glucose tolerance of South Asian and Caucasian women with previous gestational diabetes mellitus (GDM).
A retrospective follow-up study of 189 women diagnosed with GDM between 1995 and 2001. Glucose tolerance was reassessed by oral glucose tolerance test at a mean duration since pregnancy of 4.38 years.
South Asian women comprised 65% of the GDM population. Diabetes developed in 36.9% of the population, affecting more South Asian (48.6%) than Caucasian women (25.0%). Women developing diabetes were older at follow-up (mean (SD) 38.8 (5.7) vs 35.9 (5.6) years; p<0.05) and had been heavier (body mass index 31.4 (6.3) vs 27.7 (6.7) kg/m(2); p<0.05), more hyperglycaemic (Gl(0) 6.5 (1.7) vs 5.2 (1.1) mmol/l; p<0.01: G(120) 11.4 (3.3) vs 9.6 (1.8) mmol/l; p<0.01: HbA1c 6.4 (1.0) vs 5.6 (0.7); p<0.01) and more likely to require insulin during pregnancy (88.1% vs 34.0%; p<0.01). Future diabetes was associated with and predicted by HbA1c taken at GDM diagnosis in both South Asian (odds ratio 4.09, 95% confidence interval 1.35 to 12.40; p<0.05) and Caucasian women (OR 9.15, 95% CI 1.91 to 43.87; p<0.01) as well as by previously reported risk factors of increasing age at follow-up, pregnancy weight, increasing hyperglycaemia and insulin requirement during pregnancy.
GDM represents a significant risk factor for future DM development regardless of ethnicity. Glycated haemoglobin values at GDM diagnosis have value in predicting future diabetes mellitus.
评估既往患有妊娠期糖尿病(GDM)的南亚和白种女性的糖耐量。
对189名在1995年至2001年间被诊断为GDM的女性进行回顾性随访研究。在距妊娠平均4.38年时,通过口服葡萄糖耐量试验重新评估糖耐量。
南亚女性占GDM人群的65%。该人群中36.9%患糖尿病,其中南亚女性(48.6%)比白种女性(25.0%)受影响更多。患糖尿病的女性在随访时年龄更大(平均(标准差)38.8(5.7)岁对35.9(5.6)岁;p<0.05)且体重更重(体重指数31.4(6.3)对27.7(6.7)kg/m²;p<0.05),血糖更高(空腹血糖6.5(1.7)对5.2(1.1)mmol/L;p<0.01:服糖后120分钟血糖11.4(3.3)对9.6(1.8)mmol/L;p<0.01:糖化血红蛋白6.4(1.0)对5.6(0.7);p<0.01),且孕期更可能需要胰岛素治疗(88.1%对34.0%;p<0.01)。在南亚女性(优势比4.09,95%置信区间1.35至12.40;p<0.05)和白种女性(优势比9.15,95%置信区间1.91至43.87;p<0.01)中,未来患糖尿病均与GDM诊断时的糖化血红蛋白相关且可由其预测,同时也与先前报道的随访时年龄增加、孕期体重增加、血糖升高及孕期胰岛素需求等危险因素相关。
无论种族如何,GDM都是未来发生糖尿病的重要危险因素。GDM诊断时的糖化血红蛋白值对预测未来糖尿病具有价值。